Day 1 Recap: Elevate-Derm Summer Conference 2025

The first day of Elevate Derm Summer is complete! Check out our Day 1 recap below. To stay informed with the latest insights live from Park City, Utah, subscribe to receive our eNewsletters.

Remibrutinib Shows Rapid and Sustained Improvement in CSU Activity Score Bands

In a poster presented at the Elevate-Derm Summer Conference from July 23 to 27, 2025, in Park City, Utah, new data reveals a positive shift in weekly Urticaria Activity Score (UAS7) bands after long-term treatment with remibrutinib in patients with chronic spontaneous urticaria (CSU).

Elevate-Derm 2025: Emerging Trends and Therapies in Clinical Research

At the Elevate-Derm Summer Conference from July 23 to 27, 2025, in Park City, Utah, Eileen Cheever, MPAS, PA-C, led a literature review on emerging trends and therapies in the dermatology space for 2025. This innovative research from the last year explored diagnosis methods, treatment modalities, and public health initiatives for providers to consider in practice.

Practical Approaches to Patch Testing and JAK Inhibitor Optimization in Atopic Dermatitis

“Patch testing can seem very scary and overwhelming, but it can be transformative for patients,” Walter Liszewksi, MD, said in an interview at the 2025 Elevate-Derm Summer Conference in Park City, Utah.

Liszewksi, a board-certified dermatologist and associate professor of dermatology at the Northwestern Feinberg School of Medicine in Chicago, Illinois, presented numerous sessions at the 4-day conference. In his interview, Liszewski presented key highlights on contact dermatitis, patch testing, JAK inhibitors for atopic dermatitis (AD), and dosing techniques.

Dermatology Times is also attending the 2025 Society for Pediatric Dermatology annual meeting and the DERM 2025 NP/PA Conference this weekend. Turn on our social media notifications and keep up with all the latest conference coverage here.